首页> 外文期刊>ACS applied materials & interfaces >Encapsulation of an Adamantane-Doxorubicin Prodrug in pH-Responsive Polysaccharide Capsules for Controlled Release
【24h】

Encapsulation of an Adamantane-Doxorubicin Prodrug in pH-Responsive Polysaccharide Capsules for Controlled Release

机译:金刚烷-阿霉素前药在pH响应多糖胶囊中的控释封装。

获取原文
获取原文并翻译 | 示例
       

摘要

Supramolecular microcapsules (SMCs) with the drug-loaded wall layers for pH-controlled drug delivery were designed and prepared. By using layer-by-layer (LbL) technique, the SMCs were constructed based on the self-assembly between polyaldenhyde dextran-graft-adamantane (PAD-g-AD) and carbox-ymethyl dextran-graft-β-CD (CMD-g-β-CD) on CaCO3 particles via host-guest interaction. Simultaneously, adamantine-modified doxorubicin (AD-Dox) was also loaded on the LbL wall via host-guest interaction. The in vitro drug release study was carried out at different pHs. Because the AD groups were linked with PAD (PAD-g-AD) or Dox (AD-Dox) by pH-cleavable hydrazone bonds, AD moieties can be removed under the weak acidic condition, leading to destruction of SMCs and release of Dox. The pH-controlled drug release can enhance the uptake by tumor cells and thus achieve improved cancer therapy efficiency.
机译:设计并制备了带有载药壁层的超分子微胶囊(SMCs),用于控制pH值。通过使用逐层(LbL)技术,基于聚醛葡聚糖-接枝-金刚烷(PAD-g-AD)和羧甲基葡聚糖-接枝-β-CD(CMD-经由客体-客体相互作用在CaCO3颗粒上的g-β-CD)。同时,金刚烷修饰的阿霉素(AD-Dox)也通过宿主-客体相互作用被装载在LbL壁上。在不同的pH下进行了体外药物释放研究。因为AD基团通过pH可裂解的bonds键与PAD(PAD-g-AD)或Dox(AD-Dox)相连,所以在弱酸性条件下可以除去AD部分,从而导致SMC的破坏和Dox的释放。 pH控制的药物释放可以增强肿瘤细胞的吸收,从而提高癌症治疗效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号